NEW BIOTECHNOLOGICAL SYSTEMS IPSC FOR PHARMACEUTICAL DEVELOPMENT IN THE AREA OF NEURODEGENERATIVE DISEASES (Q2041388): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item) |
(Changed an Item: Label in wikidata changed) |
||
| label / en | label / en | ||
NEW BIOTECHNOLOGICAL SYSTEMS IPSC FOR PHARMACEUTICAL DEVELOPMENT IN THE AREA OF NEURODEGENERATIVE DISEASES | |||
Revision as of 08:41, 17 March 2020
Project in Italy financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | NEW BIOTECHNOLOGICAL SYSTEMS IPSC FOR PHARMACEUTICAL DEVELOPMENT IN THE AREA OF NEURODEGENERATIVE DISEASES |
Project in Italy financed by DG Regio |
Statements
1,379,705.73 Euro
0 references
2,759,411.46 Euro
0 references
50.0 percent
0 references
27 September 2016
0 references
29 November 2019
0 references
BIOREP S.R.L.
0 references
AXXAM SPA
0 references
CNR - CONSIGLIO NAZIONALE DELLE RICERCHE
0 references
UNIVERSITA' VITA-SALUTE SAN RAFFAELE
0 references
I.M.S. - ISTITUTO DI MANAGEMENT SANITARIO S.R.L.
0 references
45°32'12.05"N, 9°11'15.83"E
0 references
IL PROGETTO IPSLIGHT FOCALIZZATO SULLO SVILUPPO TECNOLOGICO DI MODELLI IPSC (INDUCED PLURIPOTENT STEM CELL) APPLICABILI ALLA RICERCA FARMACEUTICA NELLAMBITO DELLE PATOLOGIE DEGENERATIVE CRONICHE E SULLA VALIDAZIONE E APPLICAZIONE DI TALI MODELLI IN COMBINAZIONE CON METODICHE ALLAVANGUARDIA DI HIGH-CONTENT E HIGH-THROUGHPUT SCREENING UTILIZZATE PER LIDENTIFICAZIONE DI POTENZIALI FARMACI. IL FOCUS PRIMARIO SULLA PATOLOGIA DI PARKINSON (PD - PARKINSONS DISEASE), UNA MALATTIA IN RAPIDA CRE (Italian)
0 references
Identifiers
E76D17000120009
0 references